Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Faces Suit By 80 Chinese Families Over Baby Products

This article was originally published in PharmAsia News

Executive Summary

Eighty Chinese families are considering a class action suit against Johnson & Johnson, alleging its baby products harmed their children. A legal support group of more than 50 lawyers representing the families said it would submit the cases to the courts in April. At issue are the company's baby bath products, with one batch found to have 1,4-dioxane, a substance unregulated in China. The State FDA and the General Administration of Quality Supervision, Inspection and Quarantine have disagreed over the level of suspect contents in the products. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel